Viral Variants: How mutations affect function
A new study reveals how naturally occurring mutations affect the biophysical properties of nucleocapsid proteins in SARS-CoV-2.
- Department of Physics and Astronomy, University of California, Riverside, United States
The COVID-19 pandemic has inflicted enormous societal, economic, and personal costs to populations around the world. It has resulted in hundreds of millions of infections, millions of deaths as well as lingering effects such as persistent symptoms and long COVID. Combatting the virus that causes COVID-19, known as SARS-CoV-2, as well as other viruses that could cause future pandemics, requires an understanding of the basic mechanisms through which viruses evolve and exert their effects.
Every person infected with COVID-19 carries their own pool of viral variants, which each contain a unique set of mutations in their genome. State-of-the-art sequencing technology has allowed an organization known as the Global Initiative on Sharing All Influenza Data to create a SARS-CoV-2 repository, which currently contains around 17 million different viral genome sequences (Elbe and Buckland-Merrett, 2017). This provides unparalleled insight into how mutations correlate with the evolution and emergence of SARS-CoV-2 variants of concern, such as delta and omicron.
However, despite this wealth of available sequencing information, our understanding of how these genetic changes actually impact how variants behave, such as their ability to infect cells and the severity of symptoms they cause, is lacking. Now, in eLife, Peter Schuck and colleagues at the National Institutes of Health – including Ai Nguyen as first author – report how mutations affect a structural protein in SARS-CoV-2 that is responsible for packaging and protecting the viral genome (Nguyen et al., 2024).
Nguyen et al. focused their study on nucleocapsid protein, the most abundant SARS-CoV-2 protein in infected cells, which is typically the molecule probed by at-home tests for the virus (Finkel et al., 2021; Frank et al., 2022). The primary role of the nucleocapsid protein is to package the genomic material of SARS-CoV-2 into the shell of the viral particle. But nucleocapsid protein also binds to many proteins in the host cell, which can modify stress and immune responses that may kill the virus or affect the severity of the infection (Chen et al., 2020; Gordon et al., 2020; Li et al., 2020). These interactions are determined by the structure and biophysical properties of nucleocapsid protein, such as its electrical charge and hydrophobicity.
By studying available genetic sequences of SARS-CoV-2 nucleocapsid proteins, Nguyen et al. found that most mutations lie in intrinsically disordered regions of the protein (Figure 1). These parts of the protein are highly flexible and do not fold into any rigidly defined structure. As such, they are more tolerant to a wider diversity of changes and mutations than other, more highly ordered segments of the protein.
Figure 1
Naturally occurring mutations in the nucleocapsid protein of SARS-CoV-2.
(A) Space filling, (B) ribbon, and (C) domain representation of a single SARS-CoV-2 nucleocapsid protein. Nguyen et al. identified that most mutations occur in intrinsically disordered regions of the protein – the N-arm (red), linker (green), and C-arm (blue) – as opposed to more structured regions, such as the N-terminal (grey) and C-terminal (cyan) domains.
Image credit: Atomic coordinates used from Casasanta et al., 2023 and graphics in (A) and (B) made using Visual Molecular Dynamics (Humphrey et al., 1996).
Nguyen et al. then used computational methods to calculate how the behaviour of nucleocapsid proteins would be expected to change in response to each of the mutations they had detected. This showed that while single mutations in the intrinsically disordered regions cause a broader distribution of effects than those in structured regions of the protein, the biophysical properties of the protein were, surprisingly, largely conserved. Moreover, Nguyen et al. demonstrated that the intrinsically disordered regions show little sequence similarity to related viruses, such as SARS-CoV-1, Middle Eastern Respiratory Syndrome and other coronaviruses. However, the biophysical properties of these regions, such as their polarity and hydrophobicity, were similar across the different viruses.
To investigate further, Nguyen et al. carried out experiments on nucleocapsid proteins which had been purified from SARS-CoV-2 and contained mutations found in several variants of interest. This revealed that when multiple mutations are present, this leads to significant – and sometimes compensatory – biophysical changes. This included changes in the thermal stability of the protein, its ability to self-associate into multi-protein complexes, and how it assembles into larger structures. These effects demonstrate how mutations in intrinsically disordered regions can impact the entire structure and function of a protein. Additionally, this emphasizes why it is difficult to assign variant properties and fitness effects to a single mutation.
The findings of Nguyen et al. suggest that the biophysical properties of intrinsically disordered regions – such as their charge, polarity and hydrophobicity – may contribute to determining the behavior and interactions of nucleocapsid proteins. This could also be the case for other SARS-CoV-2 proteins, as well as proteins in other infectious viruses. These properties may place constraints on the mutations that nucleocapsid proteins can tolerate while still remaining functional. Furthermore, the findings of Nguyen et al. could provide a foundation for understanding how genomic sequencing data can be used to predict the effects of mutations in viruses.
References
-
Structural insights of the SARS-CoV-2 nucleocapsid protein: Implications for the inner-workings of rapid antigen testsMicroscopy and Microanalysis 29:649–657.https://doi.org/10.1093/micmic/ozac036
-
VMD: visual molecular dynamicsJournal of Molecular Graphics 14:33–38.https://doi.org/10.1016/0263-7855(96)00018-5
Article and author information
Author details
Publication history
Copyright
© 2024, Kuhlman
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 610
- views
-
- 74
- downloads
-
- 0
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Viral Variants: How mutations affect function
eLife 13:e99991.
https://doi.org/10.7554/eLife.99991
Further reading
-
- Cell Biology
- Microbiology and Infectious Disease
Zika virus (ZIKV) infection causes significant human disease that, with no approved treatment or vaccine, constitutes a major public health concern. Its life cycle entirely relies on the cytoplasmic fate of the viral RNA genome (vRNA) through a fine-tuned equilibrium between vRNA translation, replication, and packaging into new virions, all within virus-induced replication organelles (vROs). In this study, with an RNA interference (RNAi) mini-screening and subsequent functional characterization, we have identified insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) as a new host dependency factor that regulates vRNA synthesis. In infected cells, IGF2BP2 associates with viral NS5 polymerase and redistributes to the perinuclear viral replication compartment. Combined fluorescence in situ hybridization-based confocal imaging, in vitro binding assays, and immunoprecipitation coupled to RT-qPCR showed that IGF2BP2 directly interacts with ZIKV vRNA 3’ nontranslated region. Using ZIKV sub-genomic replicons and a replication-independent vRO induction system, we demonstrated that IGF2BP2 knockdown impairs de novo vRO biogenesis and, consistently, vRNA synthesis. Finally, the analysis of immunopurified IGF2BP2 complex using quantitative mass spectrometry and RT-qPCR revealed that ZIKV infection alters the protein and RNA interactomes of IGF2BP2. Altogether, our data support that ZIKV hijacks and remodels the IGF2BP2 ribonucleoprotein complex to regulate vRO biogenesis and vRNA neosynthesis.
-
- Genetics and Genomics
- Microbiology and Infectious Disease
The sustained success of Mycobacterium tuberculosis as a pathogen arises from its ability to persist within macrophages for extended periods and its limited responsiveness to antibiotics. Furthermore, the high incidence of resistance to the few available antituberculosis drugs is a significant concern, especially since the driving forces of the emergence of drug resistance are not clear. Drug-resistant strains of Mycobacterium tuberculosis can emerge through de novo mutations, however, mycobacterial mutation rates are low. To unravel the effects of antibiotic pressure on genome stability, we determined the genetic variability, phenotypic tolerance, DNA repair system activation, and dNTP pool upon treatment with current antibiotics using Mycobacterium smegmatis. Whole-genome sequencing revealed no significant increase in mutation rates after prolonged exposure to first-line antibiotics. However, the phenotypic fluctuation assay indicated rapid adaptation to antibiotics mediated by non-genetic factors. The upregulation of DNA repair genes, measured using qPCR, suggests that genomic integrity may be maintained through the activation of specific DNA repair pathways. Our results, indicating that antibiotic exposure does not result in de novo adaptive mutagenesis under laboratory conditions, do not lend support to the model suggesting antibiotic resistance development through drug pressure-induced microevolution.
